Charles River Laboratories International Inc (CRL) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Charles River Laboratories International inc   (NYSE: CRL)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Charles River Laboratories International Inc Profitability Comparisons

Select each Category to receive further Information




CRL Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 42.76 % 65.43 % 46.08 %
Gross Margin (Q2 TTM) 30.85 % 43.26 % 65.99 % 46.3 %
Gross Profit Margin 5 Yr. Avg. 44.6 % 44.06 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 9.68 % 13.35 % 18.99 % 20.49 %
EBITDA Margin (Q2 TTM) 2.27 % 14.81 % 21.01 % 20.13 %
EBITDA Margin 5 Yr. Avg. 19.04 % 15.12 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) 11.94 % 8.21 % 16.58 % 16.05 %
Operating Margin (Q2 TTM) 2.25 % 8.63 % 17.81 % 16.34 %
Operating Margin 5 Yr. Avg. 10.84 % 8.63 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 6.41 % 10.94 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) -5.92 % 7.53 % 12.79 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. 8.63 % 7.36 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -0.08 % 5.07 % 8.15 % 11.42 %
Net Margin (Q2 TTM) -5.91 % 5.6 % 9.94 % 10.76 %
Net Margin 5 Yr. Avg. 6.47 % 5.18 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Europe
  Explore Europe Segment  -
Canada
  Explore Canada Segment  -
Asia Pacific
  Explore Asia Pacific Segment  -
Other
  Explore Other Segment  -
Service
  Explore Service Segment  -
Product
  Explore Product Segment  -
Research Models and Services
  Explore Research Models and Services Segment  20.59 %
Discovery and Safety Assessment
  Explore Discovery and Safety Assessment Segment  18.97 %
Manufacturing Support
  Explore Manufacturing Support Segment  29.7 %
United States
  Explore United States Segment  -